BC Week In Review | May 26, 2014
Clinical News

Access AccuTnl+3 troponin I assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) and the Architect Stat High Sensitive Troponin-I assay from Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.) for...
BC Week In Review | May 26, 2014
Clinical News

Elecsys Troponin T high-sensitive assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche and the Architect Stat High Sensitive Troponin-I assay from Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.) for the early rule out...
BC Week In Review | May 26, 2014
Clinical News

Architect Stat High Sensitive Troponin-I Assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) and the Architect Stat High Sensitive Troponin-I assay from Abbott for the early rule out of...
BC Week In Review | Jun 18, 2012
Clinical News

Troponin T-hs regulatory update

Roche submitted a 510(k) application to FDA for use of its TnT-hs assay on its laboratory analyzers as an aid in diagnosing myocardial infarction (MI). The electrochemiluminescence immunoassay measures the level of troponin in human...
Items per page:
1 - 4 of 4